Citigroup’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-142
| Closed | -$82 | – | 6043 |
|
|
2024
Q3 | $82 | Sell |
142
-94,210
| -100% | -$52.8K | ﹤0.01% | 5546 |
|
|
2024
Q2 | $58.3K | Buy |
94,352
+77,412
| +457% | +$65.4K | ﹤0.01% | 4495 |
|
|
2024
Q1 | $43.5K | Buy |
16,940
+4,215
| +33% | +$10.3K | ﹤0.01% | 4690 |
|
|
2023
Q4 | $26K | Buy |
12,725
+11,501
| +940% | +$21K | ﹤0.01% | 4883 |
|
|
2023
Q3 | $2.1K | Sell |
1,224
-26,423
| -96% | -$46.9K | ﹤0.01% | 4945 |
|
|
2023
Q2 | $53.9K | Sell |
27,647
-154,818
| -85% | -$363K | ﹤0.01% | 4600 |
|
|
2023
Q1 | $507K | Buy |
182,465
+43,414
| +31% | +$124K | ﹤0.01% | 3121 |
|
|
2022
Q4 | $480K | Buy |
139,051
+135,857
| +4,254% | +$388K | ﹤0.01% | 3206 |
|
|
2022
Q3 | $8K | Buy |
3,194
+1,523
| +91% | +$4.85K | ﹤0.01% | 5088 |
|
|
2022
Q2 | $4K | Sell |
1,671
-5,732
| -77% | -$15.1K | ﹤0.01% | 5730 |
|
|
2022
Q1 | $31K | Sell |
7,403
-208,323
| -97% | -$1.1M | ﹤0.01% | 4946 |
|
|
2021
Q4 | $2.77M | Buy |
215,726
+211,123
| +4,587% | +$2.34M | ﹤0.01% | 2345 |
|
|
2021
Q3 | $50K | Buy |
4,603
+1,682
| +58% | +$15.3K | ﹤0.01% | 4732 |
|
|
2021
Q2 | $27K | Sell |
2,921
-72
| -2% | -$666 | ﹤0.01% | 5147 |
|
|
2021
Q1 | $28K | Sell |
2,993
-18,466
| -86% | -$254K | ﹤0.01% | 5062 |
|
|
2020
Q4 | $85K | Buy |
21,459
+6,015
| +39% | +$18.2K | ﹤0.01% | 5661 |
|
|
2020
Q3 | $41K | Sell |
15,444
-2,608
| -14% | -$9.68K | ﹤0.01% | 5727 |
|
|
2020
Q2 | $120K | Buy |
18,052
+7,695
| +74% | +$51.8K | ﹤0.01% | 5432 |
|
|
2020
Q1 | $60K | Buy |
10,357
+1,816
| +21% | +$15.2K | ﹤0.01% | 5816 |
|
|
2019
Q4 | $77K | Buy |
8,541
+7,097
| +491% | +$59.2K | ﹤0.01% | 5978 |
|
|
2019
Q3 | $12K | Sell |
1,444
-5,057
| -78% | -$51.1K | ﹤0.01% | 6999 |
|
|
2019
Q2 | $73K | Buy |
6,501
+4,655
| +252% | +$53.2K | ﹤0.01% | 6150 |
|
|
2019
Q1 | $24K | Buy |
1,846
+23
| +1% | +$307 | ﹤0.01% | 6866 |
|
|
2018
Q4 | $28K | Buy |
+1,823
| New | +$34.8K | ﹤0.01% | 6698 |
|
Other funds holding GRTS
Citigroup's GRTS Position: Q4 2024 in Review
Citigroup sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 142 shares — an estimated $82 sold.
Citigroup first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $2.77M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.
- Citigroup reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Citigroup sold 142 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $82.
- Citigroup first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
- Citigroup's Gritstone bio, Inc. Common Stock position peaked at $2.77M in Q4 2021.
- 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.